Teicoplanin is a glycopeptide antibacterial agent that has a long serum half-life and
therefore takes time to achieve steady-state conditions. An appropriate initial dosing is …

An initial loading procedure has been recommended to enable teicoplanin to promptly reach
an effective serum concentration for the treatment of methicillin-resistant Staphylococcus …

Teicoplanin has a long serum half-life, and therefore it takes time to reach a steady-state
concentration. An initial loading procedure has been recommended for teicoplanin to enable …

Background Teicoplanin is a glycopeptide antibiotic that has been used to treat serious,
invasive infections caused by Gram-positive bacteria. The area under the drug concentration …

Objectives: Teicoplanin, a glycopeptide, is regarded as among the drug choices for
methicillin-resistant Staphylococcus aureus (MRSA) infections. Few studies have evaluated …

Background Teicoplanin is a glycopeptide antibiotic that is widely used in clinical practice for
the treatment of infections caused by drug-resistant Gram-positive bacteria. The aim of this …

Background A trough concentration (C min)≥ 20 μg/mL of teicoplanin is recommended for
the treatment of serious methicillin-resistant Staphylococcus aureus (MRSA) infections …

Trough serum teicoplanin concentrations were compared in healthy adults following
intravenous administration of one of two regimens:(i) 12 mg/kg of body weight every 12 h for …

Background Owing to its low risk of adverse effects, teicoplanin has been extensively used
in patients with infections caused by MRSA. To promote the better management of patients …

Twenty-five published clinical studies were reviewed in which teicoplanin serum
concentrations were determined. A variety of assay methods were used, including bioassay …